Humana price target raised to $246 from $189 at RBC Capital

RBC Capital analyst Ben Hendrix raised the firm’s price target on Humana (HUM) to $246 from $189 and keeps a Sector Perform rating on the shares after its Q1 earnings beat. The firm notes investors digested management commentary around current cost trends, expressing confidence in claims visibility through February, though RBC remains cautious on cost trends given Humana’s outside Medicare Advantage membership growth and less visibility on March claims data, the analyst tells investors in a research note.